Shust Y. Infertility. In: Berek J.S. Novak’s Gynecolo-gy. 13th Edition. Philadelphia: Lippincott Williams & Willkins.2002;pp:973-1046.
Speroff L., Glass R.H., kase N.G. Clinical gynecologic endocrinology and infertility. 6th Edition. Philadelphia: Lippincott.2005;pp:1014-1058.
Gardner D.K., Howles C.M., Weissmann A., et al. Textbook of Assisted Reproductive Techniques. 2nd Edition. Florencel, Toms.2002;pp:429-539.
Tobar Hicks A.N., Fox M.D., Sancher- Remos L. Clinical characteristics of patients with an abnormal clomiphene citrate challenge test.Am J Obstet Gynecol. 2003;189(2):348-52.
Jain T., soules M.R., Collins J.A. Comparison of basal follicle stimulating hormone versus the clomiphene cit-rate challenge test for ovarian reserve screening. Fertil Steril.2004;82(1):180-5.
Bukulmez O., Arici A. Assessment of ovarian reserve. Curr Opin Obstet Gynecol.2004;16(3): 231-7.
Morett C., Toscano V. Dynamic evaluation of ovarion reserve and abnormal androgen excess in woman. Endocrinol Invest.2003;27(7):114-23.
Navot D., Rosenwak S.Z., Margalioth E.J. Prognostic of female fecundity. Lancet.1987;11: 645-7.
Hofmann G.E., Khoury J., Thie J. Recurrent Pregnan-cy loss and diminished ovarian reserve. Fertil Steril. 2000;74(6):1192-5.
Scott R.T., Leonardi M.R., Hofmann G.E., Illions E. L., Neal G.S., Narot D.A prospective evaluation of clo- miphen citrate challenge test. Screening in the general infertility population. Obstet Gynecol.1993;82:539-45.
Levi A.J., Ragnavlt M.F., Bergh P.A., Drews M.R. Reproductive outcome in patients with diminished ova-rian reserve. Fertil Steril.2001; 76(4):666-76.
Giovanna T., Chiattarino F., Regetti W., Nicolosi A., Aaagna F. Case control study on risk factors for prema-ture ovarian failure. Gynecol Obstet Invest.2001;51:40-3.
Morett C., Toscano V. Dynamic evaluation of ovari-an reserve and abnormal androgen excess in women. Endocrinol Invest.2003;27(7):114-23.